HUTCHMED (China) Limited

HMDCF · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Revenue$138,839$138,839$162,260$162,260
% Growth0%-14.4%0%
Cost of Goods Sold$83,789$83,789$190,429$190,429
Gross Profit$55,050$55,050-$28,169-$28,169
% Margin39.7%39.7%-17.4%-17.4%
R&D Expenses$35,995$35,995$59,055$59,055
G&A Expenses$13,876$13,876$32,148$32,148
SG&A Expenses$20,812$20,812$27,551$27,551
Sales & Mktg Exp.$6,937$6,937$24,309$24,309
Other Operating Expenses$0$0-$106,683-$106,683
Operating Expenses$56,807$56,807-$20,077-$20,077
Operating Income-$1,757-$1,757-$8,092-$8,092
% Margin-1.3%-1.3%-5%-5%
Other Income/Exp. Net$261,116$261,116$16,248$16,248
Pre-Tax Income$259,359$259,359$8,156$8,156
Tax Expense$31,581$31,581$2,153$2,153
Net Income$227,477$227,477$5,964$5,964
% Margin163.8%163.8%3.7%3.7%
EPS0.270.270.0070.007
% Growth0%3,757.1%0%
EPS Diluted0.260.260.0050.005
Weighted Avg Shares Out874,912874,9121,192,0851,192,085
Weighted Avg Shares Out Dil872,565872,565873,124873,124
Supplemental Information
Interest Income$0$0$18,604$18,604
Interest Expense$0$0$0$0
Depreciation & Amortization$3,059$3,059$3,045$3,045
EBITDA$1,302$1,302-$5,048-$5,048
% Margin0.9%0.9%-3.1%-3.1%